Does ROSUVASTATIN Cause Dyspnoea exertional? 404 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 404 reports of Dyspnoea exertional have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 1.1% of all adverse event reports for ROSUVASTATIN.
404
Reports of Dyspnoea exertional with ROSUVASTATIN
1.1%
of all ROSUVASTATIN reports
2
Deaths
212
Hospitalizations
How Dangerous Is Dyspnoea exertional From ROSUVASTATIN?
Of the 404 reports, 2 (0.5%) resulted in death, 212 (52.5%) required hospitalization, and 20 (5.0%) were considered life-threatening.
Is Dyspnoea exertional Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 404 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Dyspnoea exertional?
TREPROSTINIL (3,378)
ALBUTEROL (2,190)
MACITENTAN (1,660)
AMBRISENTAN (1,655)
PREDNISONE (1,319)
TIOTROPIUM (1,137)
MEPOLIZUMAB (1,109)
BUDESONIDE\FORMOTEROL (1,038)
OMALIZUMAB (995)
EPOPROSTENOL (938)
Which ROSUVASTATIN Alternatives Have Lower Dyspnoea exertional Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN